Faculty
CoBrCa is delighted to welcome our esteemed faculty – experts in the field of breast cancer.
Dr. Luis Pinillos Ashton
Doctor in Medicine- Cayetano Heredia University
Radiation Oncologist- Oncosalud AUNA
Fellow of the Royal College of Radiology England FRCR
Emeritus Professor- Universidad Cayetano Heredia
Honorary Professor- Universidad Ricardo Palma
Founding President Oncosalud
Founding President ALATRO( Latín american radiotherapy society)
Former Peruvian Minister of Health
Former Director of INEN (National Cancer Institute)
Former President of CLACTA (Latín American Coalition for Tobacco Control)
Former member Medical Committee ICRP
Former Peruvian representative to UNSCEAR
Founding President of COLAT. (anti tobacco national coalition)
Academician of the Peruvian National Academy of Medicine
Joseana Ayala, Peru
Dr. Enrique Bargalló Rocha is a distinguished breast cancer specialist with over 20 years of experience at leading medical institutions, including ABC Medical Center Observatorio. He earned his medical degree from La Salle University and completed his residency in General Surgery and fellowship in Oncologic Surgery at the National Autonomous University of Mexico (UNAM). He currently serves as the Head of the Breast Tumor Department at the National Cancer Institute of Mexico. Throughout his career, Dr. Bargalló has led numerous programs and initiatives, most notably the establishment of the Functional Breast Tumor Unit. He has integrated advanced reconstructive techniques into surgical care, including the use of free vascularized flaps through microsurgery, implant-based reconstruction, and oncoplastic procedures. For patients with early-stage breast lesions, he utilizes intraoperative radiotherapy. To reduce complications from axillary lymph node dissections, he has implemented the sentinel lymph node biopsy technique. Dr. Bargalló is also an expert in the use of genomic signatures to assess the risk of breast cancer recurrence, enabling him to tailor treatments and improve patient outcomes. He is an active member of The Cancer Genomics Community (CCGCoP) —a network dedicated to advancing knowledge and collaboration in cancer genetics and genomics— and recently participated in the “Intensive Course in Genetic Cancer Risk Assessment.”
Yanet Carrasco Rojas
Cirujana Oncóloga Mastóloga
Médico asistente en Arequipa Perú
Estudios de pre grado y post grado en la Universidad Católica de Santa María Arequipa
Residencia médica de Cirugía Oncológica en el Hospital Carlos Alberto Seguin Escobedo Essalud Arequipa
Máster en Senología (Mastologia) Universidad de Barcelona
Estancia formativa Hospital Abente y Lago A Coruña, España
Estancia formativa Instituto Valenciano de Oncología, España
Miembro de la Sociedad Peruana de Mastologia
Miembro de la Sociedad Peruana de Cirugía Oncológica
Miembro City Cáncer Challenge Arequipa Perú
Gerardo Castorena Rojí
Surgical Oncologist
Breast Surgeon
– Was born in México City on March of 1968.
– La Salle University School of Medicine Graduate (Mexico City 1992).
– Medical Internship in The American British Cowdray Medical Center I.A.P. (Mexico City 1992-1994)
– General Surgery Resident in The American British Cowdray Medical Center I.A.P (Mexico City 1995-1999).
– Surgical Oncology Resident in Centro Médico Nacional 20 de Noviembre I.S.S.S.T.E. (Mexico City 2001-2004)
– Visitorships in several Breast Oncology Services in the United States and Western Europe (2004).
– Author and Co-Author in scientific papers published in National and International Medical Journals.
– Author and collaborator in non-scientific health-related publications targeted for general audiences.
– Medical consultant for NGO’s fighting cancer. Also Medical Director of Fundación Bella and Senior Consultant for Avon’s “Avon’s Cruzade against Breast Cancer”
– Invited professor in Universidad Nacional Autónoma de México for undergraduate and graduate medical courses regarding Breast Cancer.
– National and International speaker in Medical Education targeted in patients empowerment.
– Bestselling Author of “20 Answers for Breast Cancer” (“20 Respuestas para Cáncer de Mama”).
– Former Director for the Breast Cancer Program for the Health Department in Mexico City.
– Former CMO for The American British Cowdray Medical Center I.A.P.’s Innovation Center.
– Senior Consultant in Medical Services Quality Issues for several government and private Health Institutions.
– Former Medical Liason for NFL (National Football League) México.
– Top 25 Doctors in Mexico Award by Top Doctors International (2017)
– Founder and CMO of Mexico Breast Center, a novel initiative for integral Breast Health in Mexico City.
Dr. Rosa Cebrián
Medical Surgeon Universidad Nacional Mayor de San Marcos.
Radiologist at the Universidad Mayor de San Marcos Hospital Headquarters National Institute of Neoplastic Diseases.
Radiology in Mammography from 1995-2013 at the Edgardo Rebagliati Martins National Hospital.
Physician at the Institute of Breast Imaging from 1995 -2025.
Master’s Degree in Applied Mastology and Breast Cancer Treatment CEU San Pablo Spain.
Member of the Peruvian Society of Radiology.
Member of the Peruvian Society of Mastology.
Member of the Inter-American College of Radiology.
Javier Cortés, MD PhD
• International Breast Cancer Center (IBCC), Barcelona, Spain
• Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain
• Medica Scentia Innovation Research (MedSIR), Barcelona, Spain & New Jersey, US
Dr. Javier Cortes received a degree in Medicine and Surgery from the Universidad Autónoma de Madrid in 1996, specialist in Medical Oncology by the Clínica Universitaria de Navarra, and awarded the title of Doctor in Medical Oncology from the University of Navarra in 2002. From June 2003 to July 2015, he has worked in the Department of Medical Oncology at the Hospital Vall d’Hebron, Barcelona, where he has been Coordinator of the Teaching and Training Programme for Residents in Oncology. In addition he was the Head of the Breast Cancer Program from July 2006 to August 2015. From September 2015 to October 2018, he has been Head of the Breast Cancer and Gynecological tumors at Ramon y Cajal University Hospital in Madrid. Dr. Cortes was the Head of the Breast Cancer Program at IOB Institute of Oncology, Quironsalud group, in both Madrid and Barcelona, from 2011 to September 2020. He has been Senior Clinical Investigator of the Breast Cancer Research Program at Vall d’Hebron Institute of Oncology from 2011 to February 2022.
Dr. Cortés is the Head of the International Breast Cancer Centre (IBCC) in Barcelona, founding partner of Medica Scientia innovation Research (MedSIR), a company involved in the clinical development of clinical trials.
In addition to his medical specialties, he has two master degrees in “Medical Direction and Clinical Management” by the Universidad Nacional de Educación a Distancia (UNED) and “Research methodology in Health Sciences” by the Universidad Autonoma de Barcelona and a degree in “Statistics in Health Sciences” by the Universidad Autonoma de Barcelona.
He has contributed to over 430 peer-reviewed publications, especially about breast tumours and new drugs and more than 800 communications at different conferences. He actively participates in the development of numerous international clinical trials, and he is an ad hoc reviewer of various oncology journals, including, New England Journal of Medicine, Lancet, Lancet Oncology, Annals of Oncology or Journal of Clinical Oncology, among many others
Dr Cortés is an active member of the Spanish, European, and American Societies of Medical Oncology (SEOM, ESMO, ASCO). In addition, he is a member of the Scientific Committee of the European Society for Medical Oncology (ESMO), of the Scientific Committee of the European Breast Cancer Conference (EBCC), has been chair for breast cancer at the ESMO 2020 congress, and co-chair of the same section in the congress of the American Association for Cancer Research (AACR) 2020, as well as the immunotherapy area of the AACR 2021 congress. He is a member of the expert panel that develops the treatment guidelines for metastatic breast cancer of the European Society for Medical Oncology, member of the ABC Conference, member of the ASCO International Affairs Committee, member of the executive panel in charge of SABCS Strategic Planning, and co-organizer of the Annual Congress of Controversies in Breast Cancer (CoBrCa).
In addition, according to the American Expertscape 2023 ranking, he is considered the world’s leading expert on HER2+ and fourth world oncologist with the greatest expertise in breast cancer and in 2022 and 2023 was identified as Clarivate™ world’s most influential researchers.
Dr. Richard De Boer completed his basic medical and oncology training at the Royal Melbourne Hospital and then in 1997 undertook a 3-year breast and lung cancer clinical research fellowship at the Royal Marsden Hospital in London, working with Professor Ian Smith.
He returned to Melbourne in 2000 and since then has been a consultant medical oncologist working in both public and private practice. His primary areas of clinical interest are in breast and lung cancer, with breast cancer interests focusing on endocrine therapy and mechanisms of resistance, treatment-induced bone loss and bone metastases, and biological predictors of response/survival. He is actively involved in clinical research, and is a member of the Australian New Zealand Breast Cancer Trials Group, and head of the Breast Trials group of Cancer Trials Australia. He has authored or co-authored articles appearing in journals such as the Journal of Clinical Oncology, Annals of Oncology, The Breast and British Journal of Cancer.
Dr. Oscar Antonio Niño de Guzmán Luizaga
Estudios de pre grado Universidad Mayor de San Simón
Post grado en Ginecología y Obstetricia Universidad Católica de Córdoba Argentina
Fellowship en Cirugía Oncológica de Mamas Piel y Partes Blandas Instituto Nacional de Enfermedades Neoplásicas INEN Lima Peru
Subespecialidad en Cirugía Oncoplastica de mama título otorgado por el hospital Aventé Lago de la Coruña España
Jefe de la Unidad de Cirugía Oncológica de Mama del Instituto Oncológico Nacional I.O.N. Caja petrolera de Salud
Speaker oficial de Genomics healt /ONCOTYPE DX
Miembro del del comité científico de la Federación Latinoamericana de Mastologia FLAM(2023-2025)
Miembro del Sub comité de cancer Genito mamario de la Federación Latinoamericana de Sociedades de Obstetricia y Ginecologia (FLASOG)
DR FRANCO DOIMI GARCIA
Anátomo Patólogo – Patólogo Oncólogo
Egresado de la Universidad San Martin de Porres
Ex Jefe del Servicio de Patología Quirúrgica y Banco de Tejidos Tumorales del Instituto Nacional de Enfermedades Neoplásicas de Perú – INEN.
Fundador y Director Médico de Patología Oncológica – Oncogenomics.
Subdirector del Laboratorio Corporativo de AUNA PERÚ – ONCOSALUD.
Médico Patólogo de Liga Peruana de Lucha Contra el Cáncer
Miembro European Society of Medical Oncology – ESMO
Miembro de la European Society of Pathology – ESP
Varios artículos relacionados al cáncer de mama en revistas internacionales y ponencias en varios congresos y actividades científicas en Perú y otros países.
Nereida Esparza-Arias
Cirujana Oncóloga con capacitación en el tratamiento de tumores sólidos del adulto.
Ejercicio Profesional Institucional en el Instituto Nacional de Cancerología desde su egreso de curso de subespecialidad. Ejercicio Profesional Privado en Médica Sur y Hospital ABC en CDMX; además de Clínica OFF y Hospital Santa Fé en Jalisco.
Surgical Oncologist specialized in the management of solid tumors in adult patients.
Public healthcare practice at the National Cancer Institute (INCan) since completion of fellowship training.
Private practice at Médica Sur and ABC Medical Center in Mexico City; also affiliated with Clínica OFF and Hospital Santa Fé in Jalisco.
DRA. LIANA FALCÓN LIZARASO
Directora del Centro de Diagnóstico por Imágenes de Clínica Internacional en Lima-Perú.
Médico Radiólogo, egresada del Posgrado en radiología en el Instituto Nacional de Enfermedades neoplásicas por la Universidad Peruana Cayetano Heredia de Lima-Perú.
Médico Cirujano por la Universidad Nacional de Trujillo.
Coordinadora de la residencia en la Especialidad de Radiología en Clínica Internacional y profesora de la Universidad San Martin de Porres.
Fundadora y Jefe de la Primera Unidad de diagnóstico Integral de la mama (UDIM) en el Perú, en la clínica Internacional.
Con más de 25 años dedicada al Diagnóstico por Imágenes mamarias y cardiovasculares, siendo referente y pionera en el país de la implementación de varios estudios diagnósticos en esas ramas de la radiología.
Miembro de Sociedades médicas científicas nacionales e internacionales
Expositora en congresos nacionales e internacionales para temas de imágenes mamarias multimodalidad e imágenes cardiovasculares en resonancia magnética y tomografía multicorte cardiovascular.
Silvia Falcon Lizaraso
Medical oncologist
-Director of the Interdisciplinary Breast Cancer Unit at Aliada Oncology Center
-Coordinator of the breast cancer group of the Peruvian Society of Medical Oncology
Adriana Magalhaes de Oliveira Freitas , Florianópolis, Santa Catarina, Brazil
Breast Surgeon in Florianópolis, member of Brazilian Breast Society and president of Women Engagement for Equity in Medicine (WEEM), an independent and non-profit institute focused on discussing gender disparities in Medical Institutions in Brazil.
Monique Gary, USA
Dra. Andrea Gomero Valdéz
Médico Anatomo Patóloga CMP: 60938 / RNE: 36406 Educación:
• Anatomía Patológica | Instituto Nacional de Enfermedades Neoplásicas | 2018
• Médico Cirujano | Universidad San Martin de Porres | 2012
• Bachiller en Medicina Humana | Universidad San Martin de Porres | 2012
Cursos y talleres: • Eiboma – II Encuentro Iberoamericano de cáncer de mama | 2025 • XXV Congreso Peruano de Anatomopatológica | Asociación Peruana de Patólogos| 2024 • Actualización en Oncología Cutánea | SILADEPA| 2023
• XXIV Congreso Peruano de Patología | Asociación Peruana de Patólogos| 2021 • Observership: Gineco patología | Jackson Memorial Hospital, Miami University | 2018
Experiencia Profesional:
• R Y R Patólogos asociados S.A.C (AUNA) | Medico Anatomo Patólogo| 2023 – Actualidad • Patología Oncológica S.A.C | Médico Anatomo Patólogo| 2022 – 2023 • Hospital Nacional Guillermo Almenara | Médico Anatomo Patólogo| 2021 – 2023
• Universidad San Martin de Porres | Docente del Curso de Patología en la Facultad de Medicina Humana| 2021 – 2022
• Universidad San Martin de Porres | Docente del Curso de Histología en la Facultad de Medicina Humana| 2019 – 2019
• Área de Investigación en el Instituto Nacional de Enfermedades Neoplásicas (INEN) | Médico Anatomo Patólogo| 2018 – 2019
Dr. Henry Gomez Moreno
Medical Oncologist- Clinica Oncosalud AUNA
Associate Research Professor- Research Institute of Biomedical Sciences- Universidad Ricardo Palma
Profesor- Universidad Cayetano Heredia
Scientific Advisor- AUNA Ideas
Member of the Latin American Cooperative Oncology Group (LACOG)
Principal Investigator for the International Breast Cancer Study Group (IBCSG), the Breast Cancer Group (BIG) and the Eastern Cooperative Oncology Group (ECOG)
Member of the National Academy of Medicine of Peru
Distinguished Researcher by the National Council of Science, Technology and Technological Innovation (Concytec)
Henry Guerra, Radiologist dedicated to breast imaging.
. Pathologist-oncologist with a specialty (Italy) in breast and head and neck pathology
. Head of the Department of Pathology of the National Institute of Neoplastic Diseases (INEN) of Lima – Peru
. Coordinator of the specialty of Oncological Pathology at the Universidad Peruana Cayetano Heredia (UPCH)
. Master of Latin American Mastology (Latin American Federation of Mastology:FLAM)
. Author and co-author of multiple publications in the specialty
. Speaker at multiple medical events in the specialty
. Currently, consultant mastopatologist
Alberto Lachos Dávila
Dr. Alberto Lachos Dávila is a respected specialist in radiation oncology. He has 20 years of professional experience, along with extensive training across various areas of the specialty. He is an expert in SBRT (Stereotactic Body Radiation Therapy) and Radiosurgery, with in-depth knowledge of Intraoperative Radiotherapy, Intensity-Modulated Radiotherapy (IMRT), and Image-Guided Radiotherapy (IGRT).
He is currently the General Director of the Department of Radiotherapy and Nuclear Medicine at the National Institute of Neoplastic Diseases (INEN).
El Dr. Alberto Lachos Dávila es un respetado especialista en oncología radioterápica. Cuenta con 20 años de experiencia en la profesión, así como extensa formación en los distintos campos de la especialidad. Es un experto en Radioterapia SBRT y Radiocirugía. Con grandes conocimientos de Radioterapia Intraoperatoria, Radioterapia de intensidad modulada y radioterapia guiada por
imágenes. En la actualidad en Director General del Departamento de Radioterapia uy Medicina Nuclear del Instituto Nacional de Enfermedades Neoplásicas – INEN.
Wallter Li
• MIR Medical Oncology Specialist Training. Central University Hospital of Asturias – Oviedo. Spain.
• Fellowship in Breast Cancer – MD Anderson Cancer Center Madrid.
• Medical Oncology Staff at the Edgardo Rebagliati Martins National Hospital and Member of the Multidisciplinary Breast Cancer Unit.
• Medical Oncology Staff at the San Felipe Clinic and Medical Coordinator of the Oncology Unit.
• Physician in Charge of the Research Center – San Felipe Clinic, Principal Investigator in various clinical studies.
• Member GEICAM, GEM, SEOM, ESMO, ASCO, Peruvian Society of Mastology, SPOM
TEXT
Ronald LimonMD MSc
Clinical Oncologist
Master in Molecular Oncology Universidad Rey Juan Carlos Madrid – España
Genetics and – Cancer Genetics Harvard University
Immunology and Immuno-Oncology Harvard University
Investigator and member of different scientific societies
Expertise field: Breast Cancer
Antonio Llombart Cussac MD, PhD
Medical doctor and specialist in medical oncology. He is currently head of the Medical Oncology Service at the Arnau de Vilanova Hospital in Valencia and full professor of Clinical Oncology at the Catholic University of Valencia.
With more than 5 years of academic and research training in France and the United States, he is an international expert in breast cancer, with more than 100 indexed publications in the last 5 years. Involved in different Breast Cancer research groups, he is a founding partner and senior-expert at MedSIR (2012), a company dedicated to promoting high-impact clinical research in collaboration with the scientific community, pharmaceutical and biotech companies.
He has been secretary of the Spanish Society of Medical Oncology (1998-2002 and 2012-2016), scientific coordinator (2006-2010) and past-president (2010-2014) of the SOLTI Research Group. He is a member of different scientific societies (SEOM, ESMO, ASCO, AACR, ECO). Since 2017 he has been a reference academician of the Royal Academy of Medicine and Sciences of the Valencian Community.
Gustavo Luyo, Peru
Prof. Bruce Mann is Professor of Surgery at the University of Melbourne and Director of The Breast Service at the Royal Melbourne and Royal Women’s Hospital in Melbourne. He is on the council of Breast SurgANZ, the Scientific Advisory Committee of the ANZ Breast Cancer Trials Group and is past president of the Clinical Oncology Society of Australia. He has been involved in many clinical trials and much clinical and translational research regarding breast cancer, with his main research interest being tailoring treatment to the disease and the patient.
David Antonio Martínez Pérez, Colombia
Dr. David Antonio Martínez Pérez
Radiation Oncologist – Regional Integrator of Methodologies and Practices in Radiotherapy at AUNA
Program Director of the Preceptorship in Interventional Radiotherapy / Brachytherapy at AUNA
Director of Education and Training for LATAM at the Rayos Contra Cancer Foundation
Stuart McIntosh is Professor of Surgical Oncology at Queen’s University in Belfast, and a consultant oncoplastic breast surgeon at Belfast City Hospital.
Stuart is an experienced clinical trialist, with a particular interest in neoadjuvant, peri-surgical and treatment de-escalation studies, and is Chief Investigator for the UK SMALL trial, as well as holding surgical leadership roles in several other trials. He is also one of the Royal College of Surgeons Surgical Specialty Leads for Breast Surgery, responsible for supporting the development and delivery of breast cancer surgical trials nationally. Additionally, he chairs the Northern Ireland Cancer Trials Network, responsible for the delivery of cancer trials across the five cancer hospitals in Northern Ireland. Stuart’s laboratory research interests include the DNA damage driven immune response in breast cancer.
Gerson Mejia Via
FORMACION
– Licenciatura: Médico Cirujano, Universidad Privada Abierta Latino – América UPAL/Bolivia
– Especialización: Medicina Oncología, Instituto Nacional de Enfermedades neoplásicas INEN/Perú
– Estancia: Medicina Oncológica Neoplasias Pulmonares, Centro de Especialidades Medicas e Investigación CEMIC / Argentina
– Autor y coautor de artículos publicados en revistas nacionales e internacionales
EXPERIENCIA LABORAL, CIENTIFICA Y DOCENCIA
– Docente Fundador de la Residencia en Oncología clínica Universidad Mayor de San Simón – Hospital Viedma
– Docente Materia pregrado Oncología UPAL
– Docente Colaborador del Programa de Apoyo en la Formación de Especialistas en Salud-Oncología Clínica de la Cooperación Española en Bolivia
– Docente Investigador de Grupo EULAT
– Docente Asistencial de la Residencia de Medicina Interna, Nefrología, Hematología y Geriatría, Hospital clínico Viedma
– Jefe del Servicio de Oncología Clínica, Hospital clínico Viedma (2021-2023)
– Responsable del Comité de Tumor servicio de Oncología y Hematoncológica del Hospital Clínico Viedma (2021 – 2023)
– Responsable del Departamento de educación de Oncología del Hospital Clínico Viedma (2018 – 2022)
– Medico oncólogo Institucionalizado, Hospital clínico Viedma
– Medico oncólogo, Global Med Cancer Center
Adscripciones actuales:
– Actual Vicepresidente de Sociedad Boliviana de Cancerología SOBOCC
– Miembro de Sociedad Boliviana de Cancerología SOBOCC
– Miembro de la Sociedad Boliviana de Mastología SBM
– Vocal de Asociación Boliviana del Dolor ABD
– Miembro de EULAT
– Miembro de LABCA
– Miembro de SLAGO
– Co Fundador y Responsable de los Grupos de Estudio en cáncer SOBOCC
Pilar Montenegro Rojas, Radiologist dedicated to breast imaging.
Oncosalud AUNA Clinic Staff.
Member of the Peruvian Society of Radiology.
Peruvian Society of Mastology
Ibero-American Society of Breast Imaging SIBIM
European Breast Imaging Society EUSOBI.
Medical Residency: INEN
Mini Fellowship MCV Commonwelth university hospital Richmond Virginia Breast Center
Zaida Morante, Peru
Luis Orrego
Medical Oncologist of the Oncologists Service of the Peruvian Institute of Oncology and Radiotherapy IPOR and Clinia Ricsrdo Palma
Valentina Ovalle, MD is a Breast Radiation Oncologist at Clínica IRAM and Assistant Professor at Diego Portales University, where she also serves as Program Director for the Radiation Oncology Residency. Her clinical and academic focus includes hypofractionation breast only and breast/chest wall with regional lymph nodes, partial breast irradiation, treatment de-escalation, and patient-centered care. She is Director of the Chilean Society of Mastology and has contributed to the development of national breast cancer guidelines with the Chilean Ministry of Health. Dr. Ovalle completed a postdoctoral fellowship at MD Anderson Cancer Center and is committed to advancing evidence-based and equitable breast cancer radiotherapy.
Dr. Andy Pantoja is a Medical Surgeon, with a specialization in Oncological Surgery and a subspecialty in Oncological Surgery of Breasts, Skin and Soft Tissue Tumors. She has a solid academic and clinical background, complemented by a training stay at the Breast Pathology Unit and Breast Cancer Centre of the Vall d’Hebron Institute, attached to the Autonomous University of Barcelona (Spain), one of the leading centres in Europe in the comprehensive management of breast cancer.
His commitment to excellence has led him to participate in outstanding international training in Oncoplastic and Reconstructive Breast Surgery, such as the program at the Hospital Abente y Lago de A Coruña (Spain), and the Oncoplastic Academy Cadaver Lab Masterclass at the Nicholson Center (United States), where he perfected advanced techniques for breast conservation and reconstruction with an oncological approach.
Since 2007, Dr. Pantoja has served as Assistant Physician of the Department of Oncological Surgery of Breast, Skin and Soft Tissues of the Regional Institute of Neoplastic Diseases – IREN Norte, in the city of Trujillo, Peru. Likewise, since 2008 he has been part of the medical staff of AUNA Oncosalud Trujillo, consolidating his experience in the multidisciplinary approach to cancer patients.
He is an Associate Member of the Peruvian Society of Surgical Oncology, the Peruvian Society of Mastology and the Peruvian Society of Cancerology, which supports his active participation in the scientific and professional development of oncological surgery in the country.
Thanks to his recognized career, Dr. Andy Pantoja is today a leading figure in the surgical treatment of breast cancer and soft tissue tumors in the Northeast region of Peru, as well as in oncoplastic and reconstructive techniques, combining oncological precision with aesthetic and functional criteria for the benefit of his patients.
Nirmala Pathmanathan, Australia
Nirmala Pathmanathan
Nirmala Pathmanathan is a specialist breast pathologist. She is the Director of the Westmead Breast Cancer Institute in Sydney (a multidisciplinary breast diagnostic and treatment centre servicing Western Sydney), a specialist breast pathologist with Douglass Hanly Moir Pathology in Sydney and the Director for BreastScreen Program for Sydney West. She is a Clinical Associate Professor with the University of Sydney, Faculty of Medicine and Health.
Shelley Potter PhD FHEA FRCS
Shelley Potter is Professor of Surgical Oncology at Bristol Medical School and Consultant Oncoplastic Breast Surgeon at North Bristol NHS Trust.
Her research interests focus on improving outcomes for women with breast cancer through the development and delivery of high-quality patient-centred research. She is an experienced researcher who had led several national and international collaborative oncoplastic and reconstructive breast surgical projects including the iBRA and TEAM studies and is currently Chief Investigator for Brighter, ANTHEM and Pre-BRA. Recent work has focused on optimisation of breast cancer treatment.
Her leadership national roles include Royal College of Surgeons of England Surgical Specialty Lead for Breast Surgery, Chair of iBRA-NET and Secretary to the British Breast Group.
LIA PAMELA REBAZA
VASQUEZCIRUJANO ONCOLOGO DE MAMA,PARTES BLANDAS Y PIEL
CMP: 53369 RNE : 29708 / 24633Educación
Experiencia
2017- Hasta la Fecha – Médico Cirujano Oncólogo de mama partes blandas y piel Clinica Oncosalud – Auna
2023- Hasta la Fecha – Médico Cirujano Oncólogo de mama partes blandas y piel Clinica Guardia Civil – Auna
2016-2020 – Médico Prenvención Oncologica Oncosalud . Auna
2013- 2016 – Medico Fellow en cirugía oncológica de mamas, partes blandas y piel
Sociedades
Sociedad Peruana de Cancerología Sociedad Peruana de Mastologia
Sociedad Peruana de Cirugia Oncologica
Eubreast (European Breast Cancer Association of Surgical Trial)
Ponencias
VII Best of San Antonio Breast Cancer Symposium® PERÚ Marzo 2025 – Ponente
Ponente del IX Congreso Nacional de Mastología – Sociedad
Peruana de Mastologia . 27-28 de Setiembre 2024
VII Best of San Antonio Breast Cancer Symposium® PERÚ Marzo 2024 – Ponente
Curso Internacional Hands – on de Cirugia Oncoplastica mamaria
Agosto , Setiembre , Octubre 2023 – Co- organizadora Ponente y miembro del Comité organizador del XIII Congreso Nacional de Mastología , Sociedad de Mastologia . Noviembre
Ponente Best of San Antonio Breast Cancer Simposium Marzo 2020
Dr. Luis Schwarz is a medical oncologist trained at the National Institute of Neoplastic Diseases, affiliated with Universidad Peruana Cayetano Heredia, from which he graduated in 2010. From 2012 to 2017, he served as a postdoctoral fellow in translational oncology in Dr. Carlos Arteaga’s laboratory at Vanderbilt University in the United States. His research focused on the study of genes involved in therapeutic resistance in breast cancer. Dr. Schwarz has authored and contributed to publications in leading scientific journals such as Cancer Discovery, Cancer Research, and the Journal of the National Cancer Institute, among others. He is also an active member of several scientific societies in Peru and internationally.
Dr. Schwarz previously served as Head of the Scientific Research Department at Oncosalud-Auna and is currently the Coordinator of the Breast Pathologies Group at Clínica Internacional in Lima, Peru.
Dr. Karla Sepulveda is a Professor of Radiology at Baylor College of Medicine and Medical Director of Breast Imaging at Baylor St. Luke’s Medical Center in Houston. TX. She holds the Pat Korell Endowed Professorship of Breast Imaging. Dr. Sepulveda completed her fellowship in Breast Imaging at MD Anderson Cancer Center. She is active in the American College of Radiology and Texas Radiological Society and uses this work to advocate for high value, multidisciplinary care for breast cancer patients. Her areas of professional interest include healthcare innovation, the role of radiology in precision oncology, and applications of artificial intelligence in breast imaging.
Prof. Alastair Thompson graduated from the University of Edinburgh, UK with Distinction in Surgery and subsequently trained as a Clinician Scientist and Fellow of the Royal College of Surgeons of Edinburgh. In 2014 he moved from the position of Professor of Surgical Oncology, Clinical Lead for the Dundee Cancer Centre/Experimental Cancer Medicine Centre and Foundation Director of the Clinical Research Centre, Dundee, UK to the Department of Surgical Oncology, The University of Texas, MD Anderson Cancer Center in Houston, Texas, specializing in breast cancer.
Achievements to date include setting up and chairing the Breast Cancer Campaign Breast Tissue Bank Board for the UK and Eire, leading the 12,000 patient UK National Audit of Screen Detected DCIS and, for 5 years to 2014, chairing the UK National Cancer Research Institute, Breast Clinical Studies Group (with oversight of 120 academic and commercial clinical studies in breast cancer). He actively contributes to a range of clinical trials in the prevention, early detection and therapy of breast cancer. He remains as UK Chief Investigator for a number of key trials including MINDACT, MA32 and SOLE and continues to chair the data monitoring committees and trials steering groups for several phase II drug trials and phase III surgical trials respectively in the UK.
Active in translational laboratory research, he built a breast cancer research program over 15 years in Dundee, including a xenograft program and tissue banking facility with a focus on the p53 network and drug development. He has successfully supervised 20 PhD or research MD students and currently has 4 students completing PhDs. The impact of over 200 peer reviewed research papers has included global firsts demonstrating the effect of drugs in vivo in animal models and in human cancers.
He continues to provide leadership in trials and clinical translational research with colleagues in Europe and Australasia while establishing clinical trials and laboratory collaborations in the US, through membership of the American Society of Clinical Oncology, American Association of Cancer Research, South West Oncology Group and Translational Breast Cancer Research Consortium.
Juan Manuel Trejo
Specialist in Radiation Oncology. Universidad Peruana Cayetano Heredia, Lima, Peru.
Assistant physician, radiotherapy department, Institute of Neoplastic Diseases.
Physician in charge of the head of the brachytherapy area at the Peruvian Institute of Oncology and Radiotherapy and the Ricardo Palma Clinic.
Specialist in oncological radiotherapy from the Institute of Neoplastic Diseases of Lima by Cayetano Heredia University. Physician in charge of the brachytherapy area at the Peruvian Institute of Oncology and Radiotherapy IPOR. Tutor in the area of postgraduate training at Universidad Cayetano Heredia. Master’s degree in medicine with a mention in radiotherapy from San Martín de Porres University, with rotations at the Catalan Institute of Oncology Barcelona and Girona. In the brachytherapy area at Clínica Las Americas in Medellín, Colombia. Preceptorship in head and neck cancer at Hospital H Roffo Buenos Aires, Argentina and rotation in brachytherapy at Incan in Chile. Member of the Radiotherapy Society of Peru, Cancer Society, ESTRO and ALATRA.
Dr. Natalia Isabel Valdiviezo Lama
Medical Oncologist – Clinical Researcher – University Professor
Dr. Natalia Valdiviezo is a renowned Peruvian medical oncologist with over 15 years of experience in cancer treatment and clinical research. Her academic background includes studies at the National University of Piura, Cayetano Heredia Peruvian University, the Spanish National Cancer Research Center (CNIO), and several international certifications in molecular oncology and clinical ethics.
She currently serves as an attending physician at the National Institute of Neoplastic Diseases (INEN) and ONCOSALUD, where she leads the Outpatient Chemotherapy Service and actively works as the principal investigator in multiple international phase III clinical trials focused on lung, breast, ovarian, and cervical cancer.
In the academic field, she teaches at institutions such as San Ignacio de Loyola University, San Marcos, and San Martín de Porres University, sharing her expertise with undergraduate and postgraduate students in oncology and palliative care.
She has been a speaker at international conferences and symposia across the Americas, Europe, and Asia, and is the author or co-author of more than 10 scientific publications in high-impact journals such as The New England Journal of Medicine, The Lancet Oncology, and Journal of Clinical Oncology.
She is an active member of various national and international scientific societies and currently serves as President of the Peruvian Society of Mastology. Her work stands out for promoting precision medicine in Latin America, improving equitable access to innovative treatments, and contributing to the development of national clinical guidelines in cancer care.
Areas of expertise: lung cancer, breast cancer, molecular oncology, clinical trials, precision medicine.
Carlos Vallejos, Peru
Rafael Vázquez
FORMACIÓN ACADEMICA:
• Licenciatura: Médico cirujano. Facultad de medicina de la Universidad Autónoma de Aguascalientes (1992-1999).
• Especialización: Cirugía General: Universidad Autónoma de Coahuila. (2000- 2004).
• Subespecialización: Cirugía oncológica: Instituto Nacional de Cancerología. (2004-2007)
• Maestro en Ciencias de la Salud. Instituto Politécnico Nacional
• Autor y coautor de múltiples capítulos de libros.
• Autor y coautor de artículos publicados en revistas nacionales e internacionales
EXPERIENCIA CIENTIFICA Y DOCENCIA.
• Profesor, y asistencia a múltiples Congresos Nacionales e Internacionales.
• Profesor colaborador del curso de especialización de ginecología oncología y cirugía oncológica en el INCan desde el 2008-2023.
• Profesor colaborador del curso de especialización en cirugía oncológica y enfermería oncológica del Colegio de las Fuerzas Armadas de México.
• Subdirector de Educación Médica en el Instituto Nacional de Cancerología (de feb de 2020 a octubre de 2023)
Adscripción actual:
• Médico adscrito al servicio de tumores de mama del INCan desde marzo del 2007.
• Investigador en Ciencias de la Salud: Miembro del Sistema Nacional de investigadores. SNI Nivel I.
• Miembro de la Sociedad Americana de Cirugía Oncológica. SSO
• Miembro la Asociación Mexicana de Mastología. AMM
• Vicepresidente de la Asociación Mexicana de Mastología 2023-2025
• Presidente actual de la Asociación Mexicana de Mastología (periodo 2025-2027)